US Edition
Smoking Cessation in Lung Cancer Screening: The Latest Randomized Controlled Trial Evidence - ILCN.org (ILCN/WCLC)
Summary by ILCN.org (ILCN/WCLC)
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Smoking Cessation in Lung Cancer Screening: The Latest Randomized Controlled Trial Evidence - ILCN.org (ILCN/WCLC)
Lung cancer screening (LCS) is recommended for individuals at increased risk for lung cancer based on age and smoking history.1 LCS clinical trial data show that 50-55% of participants in these studies currently smoke cigarettes, and of those, up to 90% continue smoking after LCS.2 There is strong evidence that combining smoking cessation interventions with LCS is highly cost-effective, preventing deaths from lung cancer and other causes.3 Addin…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
